These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
201 related items for PubMed ID: 19661079
1. The use of herbal preparations to alleviate climacteric disorders and risk of postmenopausal breast cancer in a German case-control study. Obi N, Chang-Claude J, Berger J, Braendle W, Slanger T, Schmidt M, Steindorf K, Ahrens W, Flesch-Janys D. Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2207-13. PubMed ID: 19661079 [Abstract] [Full Text] [Related]
2. Risk factors for hormone receptor-defined breast cancer in postmenopausal women. Rosenberg LU, Einarsdóttir K, Friman EI, Wedrén S, Dickman PW, Hall P, Magnusson C. Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2482-8. PubMed ID: 17164374 [Abstract] [Full Text] [Related]
7. Relationship between histamine2-receptor antagonist medications and risk of invasive breast cancer. Mathes RW, Malone KE, Daling JR, Porter PL, Li CI. Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):67-72. PubMed ID: 18199712 [Abstract] [Full Text] [Related]
8. Alcohol and breast cancer risk defined by estrogen and progesterone receptor status: a case-control study. Deandrea S, Talamini R, Foschi R, Montella M, Dal Maso L, Falcini F, La Vecchia C, Franceschi S, Negri E. Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2025-8. PubMed ID: 18708394 [Abstract] [Full Text] [Related]
10. Estrogen therapy and risk of breast cancer in postmenopausal women: a case-control study and results of a multivariate analysis. Lumachi F, Frigo AC, Basso U, Tombolan V, Ermani M. Menopause; 2010 Aug; 17(3):524-8. PubMed ID: 20130492 [Abstract] [Full Text] [Related]
12. Impact of hormone replacement therapy on the histologic subtype of breast cancer. Zanetti-Dällenbach RA, Krause EM, Lapaire O, Gueth U, Holzgreve W, Wight E. Arch Gynecol Obstet; 2008 Nov; 278(5):443-9. PubMed ID: 18335229 [Abstract] [Full Text] [Related]
16. Body size changes in relation to postmenopausal breast cancer among women on Long Island, New York. Eng SM, Gammon MD, Terry MB, Kushi LH, Teitelbaum SL, Britton JA, Neugut AI. Am J Epidemiol; 2005 Aug 01; 162(3):229-37. PubMed ID: 15987723 [Abstract] [Full Text] [Related]
18. Anthropometric measures, plasma adiponectin, and breast cancer risk. Tian YF, Chu CH, Wu MH, Chang CL, Yang T, Chou YC, Hsu GC, Yu CP, Yu JC, Sun CA. Endocr Relat Cancer; 2007 Sep 01; 14(3):669-77. PubMed ID: 17914097 [Abstract] [Full Text] [Related]
19. Influence of estrogen plus testosterone supplementation on breast cancer. Ness RB, Albano JD, McTiernan A, Cauley JA. Arch Intern Med; 2009 Jan 12; 169(1):41-6. PubMed ID: 19139322 [Abstract] [Full Text] [Related]
20. The association between 3-hydroxy-3-methylglutaryl conenzyme A inhibitor use and breast carcinoma risk among postmenopausal women: a case-control study. Boudreau DM, Gardner JS, Malone KE, Heckbert SR, Blough DK, Daling JR. Cancer; 2004 Jun 01; 100(11):2308-16. PubMed ID: 15160333 [Abstract] [Full Text] [Related] Page: [Next] [New Search]